Okyo PharmaOKYO
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 7 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, unchanged from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were Dauntless Investment Group, LLC ($2.5M), Citadel Advisors ($35K) and FNY Investment Advisers, LLC ($25K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2.6M |
| Exits | 2 | $1.1M |
All 13F filers, Q4 2024 → Q1 2025: 2,015,455 shares bought and 966,552 shares sold, net +1,048,903 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Dauntless Investment Group, LLC | 9.33% | New | 1,988,780 | $2.5M |
| Citadel Advisors | 0.00% | Add +32.2% | 27,404 | $35K |
| FNY Investment Advisers, LLC | 0.02% | New | 20,000 | $25K |
| Renaissance Technologies | 0.00% | Reduce -15.5% | 13,946 | $18K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $16K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $15K |
| Continuum Advisory, LLC | 0.00% | No change | 50 | $64 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.